These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1356 related articles for article (PubMed ID: 14572558)
1. Belching: dyspepsia or gastroesophageal reflux disease? Lin M; Triadafilopoulos G Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558 [TBL] [Abstract][Full Text] [Related]
2. Features of gastroesophageal reflux disease in women. Lin M; Gerson LB; Lascar R; Davila M; Triadafilopoulos G Am J Gastroenterol; 2004 Aug; 99(8):1442-7. PubMed ID: 15307857 [TBL] [Abstract][Full Text] [Related]
3. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both? Tack J; Koek G; Demedts I; Sifrim D; Janssens J Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713 [TBL] [Abstract][Full Text] [Related]
4. Endoscopic implantation of enteryx for treatment of GERD: 12-month results of a prospective, multicenter trial. Johnson DA; Ganz R; Aisenberg J; Cohen LB; Devière J; Foley TR; Haber GB; Peters JH; Lehman GA Am J Gastroenterol; 2003 Sep; 98(9):1921-30. PubMed ID: 14499767 [TBL] [Abstract][Full Text] [Related]
5. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease. Watson TJ; Peters JH Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131 [TBL] [Abstract][Full Text] [Related]
6. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor? Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197 [TBL] [Abstract][Full Text] [Related]
7. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Charbel S; Khandwala F; Vaezi MF Am J Gastroenterol; 2005 Feb; 100(2):283-9. PubMed ID: 15667483 [TBL] [Abstract][Full Text] [Related]
8. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Sharma N; Agrawal A; Freeman J; Vela MF; Castell D Clin Gastroenterol Hepatol; 2008 May; 6(5):521-4. PubMed ID: 18356117 [TBL] [Abstract][Full Text] [Related]
9. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry. Ghoshal UC; Chourasia D; Tripathi S; Misra A; Singh K Scand J Gastroenterol; 2008; 43(6):654-61. PubMed ID: 18569981 [TBL] [Abstract][Full Text] [Related]
10. Air swallowing, belching, acid and non-acid reflux in patients with functional dyspepsia. Conchillo JM; Selimah M; Bredenoord AJ; Samsom M; Smout AJ Aliment Pharmacol Ther; 2007 Apr; 25(8):965-71. PubMed ID: 17403001 [TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus. Eloubeidi MA; Provenzale D Am J Gastroenterol; 2000 Aug; 95(8):1881-7. PubMed ID: 10950030 [TBL] [Abstract][Full Text] [Related]
12. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring. Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975 [TBL] [Abstract][Full Text] [Related]
13. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD). Milkes D; Gerson LB; Triadafilopoulos G Am J Gastroenterol; 2004 Jun; 99(6):991-6. PubMed ID: 15180715 [TBL] [Abstract][Full Text] [Related]
14. [Postoperative evaluation of esophageal mucosal change dynamics in patients with reflux diseases]. Wallner G; Misiuna P; Chibowski D; Polkowski W; Abramowicz K; Sory A Wiad Lek; 1997; 50 Suppl 1 Pt 1():273-81. PubMed ID: 9446369 [TBL] [Abstract][Full Text] [Related]
15. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422 [TBL] [Abstract][Full Text] [Related]
16. Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease? Tefera L; Fein M; Ritter MP; Bremner CG; Crookes PF; Peters JH; Hagen JA; DeMeester TR Am Surg; 1997 Oct; 63(10):933-6. PubMed ID: 9322676 [TBL] [Abstract][Full Text] [Related]
17. Typical GERD symptoms and esophageal pH monitoring are not enough to diagnose pharyngeal reflux. Oelschlager BK; Chang L; Pope CE; Pellegrini CA J Surg Res; 2005 Sep; 128(1):55-60. PubMed ID: 16115493 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of antireflux surgery in patients with normal preoperative 24-hour pH test results. Khajanchee YS; Hong D; Hansen PD; Swanström LL Am J Surg; 2004 May; 187(5):599-603. PubMed ID: 15135673 [TBL] [Abstract][Full Text] [Related]
19. Gastroesophageal reflux disease in children: association between symptoms and pH monitoring. Størdal K; Johannesdottir GB; Bentsen BS; Sandvik L Scand J Gastroenterol; 2005 Jun; 40(6):636-40. PubMed ID: 16036522 [TBL] [Abstract][Full Text] [Related]
20. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus. Triadafilopoulos G; Kaczynska M; Iwane M Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]